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GradingAbstract Purpose: To evaluate role of diffusion weighted MR imaging (DW MRI) in T staging of
urinary bladder carcinomaand tomeasure correlation betweenADCvalue and histopathological grade.
Patients and methods: During the period between February 2012 and April 2014, 30 patients (28 males
and 2 females) presenting with hematuria were enrolled prospectively. All patients underwent transure-
thral cystoscopy followed by standard MRI protocol and diffusion weighted MR imaging of urinary
bladder tumors and histological examination of resected specimens.
Results: Correlation between standardMR staging of bladder carcinoma and histopathological results
revealed that 26 patients (86.7%) had the same T stage while 4 patients (13.3%) were overstaged. DWI
and ADC values were able to declare the cause of overstating by discrimination between tumoral tissue
and peritumoral inﬂammation. A statistically signiﬁcant difference is found betweenADC values of the
bladder tumor and those of urine. Also a statistically signiﬁcant difference is found betweenADCvalues
of G1 and G3 (p< 0.01) and between G2 and G3 (p< 0.01) but not between G1 and G2.
Conclusion: Accurate predictions for T staging of urinary bladder carcinoma can be made by means of
DWI andADCquantiﬁcation.ADCvalue is a beneﬁcialmethod for providing information about grade
of bladder carcinomas.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Management of urinary bladder cancer is essentially dependent
upon distinguishing between superﬁcial tumors (stage T1 or
lower) and invasive tumors (stage T2 or higher) because super-
ﬁcial tumors are managed by transurethral resection with or
without intravesical chemotherapy whereas invasive tumors
are treated with radical cystectomy, radiation therapy, chemo-
therapy, or a combination. So, if preoperative imaging could be
used to precisely differentiate between the two categories of
bladder cancer, it will play an important diagnostic role (1–7).ed.
Table 1 Comparison between standard MRI staging of
bladder carcinoma and histopathological results (n= 30
patients).
Stage Method of staging
MRI staging Pathological staging
No. % No. %
Stage 1 4 13 6 0
Stage 2 20 67 20 67
Stage 3 6 20 4 0
Stage 4 0 0 0
Total 30 100 30 100
190 M.F. SherifThere is growing interest in the applications of DWI in
oncologic area for last ten years. DWI has important advanta-
ges which require no contrast medium and long imaging time.
Also it provides qualitative and quantitative information that
can be helpful for tumor assessment (3,8–10).
Diffusion weighted MR imaging is more accurate than
computed tomography as regards staging bladder cancer
(8,11), but overstaging has been reported to be a common
error when using dynamic MR imaging (3,12).
The value of diffusion-weighted (DW) MR imaging for
depicting malignant tumors (13–15) and an apparent diffusion
coefﬁcient (ADC) for characterizing tumor grades have been
suggested recently (16,17).
The aim of the study: this study aims to evaluate the role of
diffusion weighted MR imaging in T staging of urinary blad-
der cancer and to measure the correlation between ADC value
and histopathological grade.
2. Patients and methods
2.1. Population
Between February 2012 and April 2014, 42 consecutive patients
referred for pelvic MRI because of a clinical suspicion of uri-
nary bladder carcinoma were prospectively enrolled. Among
these, 30 patients (28 males and 2 females) presenting with
hematuria who underwent cystoscopy examination were
included in this study (mean age, 65 years; range, 50–80 years).
Inclusion criteria were patients who: (a) had a history of
symptoms consistent with urinary bladder carcinoma, such as
hematuria. (b) Had recent cystoscopy revealing urinary bladder
carcinoma. Exclusion criteria were the common contraindica-
tions to MRI (pacemaker, metallic foreign bodies, and
impaired renal function). 4/30 patients underwent transurethral
resection and intravesical BCG chemotherapy while 26/30
patients underwent radical cystectomy and radiotherapy. This
study was approved by the ethics committee of our institution;
an informed consent was obtained from all patients after full
explanation of the beneﬁts and risks of the procedure.
2.2. Methods
Magnetic resonance imaging was performed using 1.5 T MRI
system (General Electric Medical Systems, USA) with a pelvic
phased-array coil.
Gadolinium-based contrast agents GD-DTPA (Bayer
healthcare pharmaceutical corporation – Germany) was used
for imaging.
Patients did not undergo bowel preparation, but were
instructed to fast for at least 4 h before the exam. The standard
position for pelvic MRI is the comfortable supine position
with a bolster placed under the knees; 20 mg of hyoscine-N-
butylbromide (Buscopan) was injected 30 min before examina-
tion to reduce intestinal peristalsis.
2.3. Pulse sequences and scanning planes
For all patients the imaging protocols consisted of using multi
sections spin echo sequences with different repetition time
(TR) and echo delay time (TE) to obtain T1 weighted image
(T1 W.I.) (TR/TE = 400–600/10–20 m/s), T2 weighted image(T2 W.I.) (TR/TE = 2000–4000/100–120 m/s). T1 W.I. with
contrast, diffusion-weighted MRI (DWI) with b values of
1000 s/mm2 images were obtained in the axial and sagittal
planes (according to the site of the mass), using apparent
diffusion coefﬁcient (ADC). T1 weighted image sagittal view
was done to verify the precise position of the patient and act
as a localizer of subsequent slices. Then multiple pulse
sequences in all three orthogonal planes were used to obtain
axial images followed by coronal and sagittal images. The slice
thickness was 3–5 mm (according to the size of the mass). Post
contrast T1WI study was done after injection of Gd-DTPA in
a dose = 0.1 ml/kg.
2.4. Image analysis
The tumor margins were assessed based on the appearance of
tumor on T2-weighted imaging. Image was analyzed using
func. tool software (Signa, General Electric Medical System,
Milwaukee, WI, USA). The radiologist was blinded to the
results of cystoscopy. The apparent diffusion coefﬁcient
(ADC) values of bladder masses, urine, the normal bladder
wall, the seminal vesicle, and the transition and peripheral
zones of the prostate were measured.
2.5. Statistical analysis
Comparison between ADC values of carcinomas and sur-
rounding structures was performed with the Wilcoxon test.
Also comparison between ADC values of different histological
grades (G1, G2, and G3) was done with p value =<0.05
considered signiﬁcant. The Minitab V.17 software (Minitab
Inc. USA) was used.
3. Results
Regarding MRI Staging of 30 tumoral lesions at 30 patients
(using T1WI, T2WI, Contrast enhanced images and DWI)
there were 4 patients at stage T1 N0, 20 patients at stage T2
N1 and 6 patients at stage T3 N2. These results were compared
with histological reports of the taken specimens (Table 1). 4/30
patients underwent Trans-urethral cystoscopic biopsy while
26/30 patients underwent surgery.
On comparison between MR ﬁndings & histopathological
ﬁndings (Table 2), we found 26/30 patients had the same T
stage (Figs. 1, 3 and 4), 4/30 patients were overstaged
(Fig. 2). Regarding the overstaged patients, the pathological
Table 2 Number of correctly staged and overstaged and
understaged patients (n= 30).
Radio-pathological comparison No. of patients %
Correctly staged 26 87
Overstaged 4 13
Understaged 0 0
Fig. 1 MR images of a 70-year-old female with mild hematuria. (A) A
coronal T1 WI show tumor with intermediate SI on the left posterior
enhanced axial T1 WI shows moderate enhanced tumor with perive
diffusion with ADC value = 1.24 · 103 mm2/s. Also DWI proved the
case the MRI report proved that the mass was at stage 3b and the pa
Fig. 2 MR images of a 77-year-old male presented with painless hem
WI and (D) coronal T1 WI show tumor with intermediate SI on Rt. po
and (F) DWI shows that the mass was restricted in diffusion with ADC
proved the invasion of the muscle layer and perivesical fat inﬁltration.
and the pathological report proved that the mass was at stage 2 TCC
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layer only (stage 2b) while MRI report showed that there was
focal invasion of the perivesical fat (stage 3b) in addition to the
muscle invasion. The other 2 overstaged patients, pathological
reports revealed that tumor invading the lamina propria
only (stage I) while MRI report proved invasion of the muscle
layer in addition to lamina propria (stage II). Histologicalxial T2-WI and (B) coronal T2 WI and (C) Sagittal T1 WI and (D)
side of the bladder with perivesical fat inﬁltration. (E) contrast-
sical standings. (F) DWI shows that the mass was restricted in
invasion of the muscle layer and perivesical fat inﬁltration. In this
thological report proved that the mass was at stage 3b TCC (G2).
aturia. (A) Axial T2-WI and (B) Axial T1 WI and (C) Coronal T2
stero-lateral wall of the bladder with perivesical fat inﬁltration. (E)
value = 1.31 + 0.11 · 103 mm2/s that suggests malignancy. DWI
In this case the MRI report proved that the mass was at stage 3b
(G2).
Fig. 3 MR images of a 65-year-old male presenting with painless hematuria and suprapubic pain. (A) Axial T2-WI and (B) Axial T1 WI
and (C) Sagittal T2 WI show tumor with intermediate SI on Rt. posterior side of the bladder (D) contrast-enhanced axial T1 WI shows
inhomogeneous enhanced tumor. The mass appears invading the muscle layer on the same side of the bladder mass. (E) and (F) DWI
showed that the mass was restricted in diffusion with ADC value (1.27 ± 0.24) · 103 mm2/s) lower than the surrounding that suggest
malignancy and proved the invasion of muscle layer. In this case the MRI report proved that the mass was at stage 2b and the pathological
report proved that the mass was at stage 2b TCC (G2).
Fig. 4 MR images of a 59-year-old male with frank hematuria. (A) Axial T2-WI and (B) axial T1 WI and (C) coronal T1 WI show
intermediate SI tumor in the form of mural thickening violating the Rt. anterior & Rt. postero-lateral side of the bladder with posterior
perivesical fat inﬁltration. (D) contrast-enhanced axial T1 WI shows moderate enhanced tumor. (E) Axial DWI shows that the mass was
restricted in diffusion and proved the invasion of the muscle layer and perivesical fat inﬁltration. (F) ADC value = 0.85 · 103 mm2/s
suggesting malignancy. In this case the MRI report proved that the mass was at stage 3b and the pathological report proved that the mass
was at stage 3b SCC (G3).
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tional cell carcinoma (TCC) in 28/30 patients (Figs. 1–3)
and squamous cell carcinoma (SCC) in 2/30 patients (Fig. 4)
(Table 3).The diffusion weighted imaging revealed that all carcinomas
were restricted in diffusion. The range and mean and standard
deviations of the ADC values (·10–3 mm2/s) were as follows:
carcinomas (0.57–2.35) 1.36 + 0.63, urine (2.81–5.10)
Table 3 Histological subtypes and their ADC values of
urinary bladder carcinomas (n= 30 patients).
Histological
results
No. of
patients
% The ADC values
TCC 28 93 (0.57–2.22) 1.39 + 1.60
SCC 2 7 (0.87–2.35) 1.61 + 1.22
Fig. 5 Boxplot showing the ADC values at different areas in
studied patients (n= 30 patients).
Table 4 ADC values in different histological grades of
urinary bladder carcinomas (n= 30 patients).
Histological grade The ADC values (mm2/s)
G1 1.27 ± 0.24 · 103
G2 1.46 ± 0.21 · 103
G3 0.86 ± 0.11 · 103
Role of diffusion weighted MR imaging in T staging of urinary bladder cancer 1933.53 + 0.51, normal bladder wall (0.91–3.89) 2.38 + 0.65,
peripheral zone of prostate (0.84–2.9) 1.89 + 0.34, transition
zone of prostate (0.61–2.90) 1.93 + 0.32 and the seminal vesicle
(1.44–3.02) 2.26 + 0.42.
A statistically signiﬁcant difference is found between ADC
values of carcinomas and those of urine (p< 0.001), normal
bladder wall (p< 0.001), prostate (p< 0.05), and seminal
vesicle (p< 0.001). There was no overlap between ADC val-
ues of tumors and urine. An overlap is detected between the
ADC values of tumors and the bladder wall, prostate, or sem-
inal vesicles (Fig. 5). Thus, there seems to be a clear cutoff
between the tumors and the urine, but not between the tumors
and the bladder wall, prostate, or seminal vesicles.
The diffusion weighted images and ADC values were able
to explain the cause of overstaging in the routine MRI exam-
ination (Fig. 2) as it can discriminate between tumoral tissue
and peritumoral inﬂammatory changes which lead to overstag-
ing where ADC value was higher in peritumoral inﬂammatory
changes than tumoral tissue, also peritumoral inﬂammatory
changes do not show high SI on DWI.
ADC values for histological subtypes were: TCC (range =
0.57–2.22) (mean = 1.39 + 1.60) and SCC (range = 0.87–
2.35) (mean = 1.61 + 1.22) (Table 3).
A statistically signiﬁcant difference is found between ADC
values in G1 and G3 (p< 0.01) and between G2 and G3
(p< 0.01) but no statistically signiﬁcant difference could be
found between G1 and G2 (Table 4).
4. Discussion
Correlation between standard MR staging of bladder carci-
noma and histopathological results revealed that 26 patients
(86.7%) had the same T stage while 4 patients (13.3%) were
overstaged. DWI and ADC values were able to declare thecause of overstating by discrimination between tumoral tissue
and peritumoral inﬂammation. A statistically signiﬁcant differ-
ence is found between ADC values of the bladder tumor and
those of urine. Also a statistically signiﬁcant difference is
found between ADC values of G1 and G3 (p< 0.01) and
between G2 and G3 (p< 0.01) but not between G1 and G2.
Regarding MRI staging of 30 patients with bladder carci-
noma, the detrusor muscle appeared as a hypoin tense line
on T2-weighted images. In patients with superﬁcial or papil-
lary tumors, this layer of the detrusor muscle was uninter-
rupted. In patients with muscle-invasive tumors, the low
signal intensity of the detrusor muscle was interrupted by the
tumor. In patients with extravesical disease spread, a clear
extravesical mass could be seen inﬁltrating the perivesical fat
in stage T3b disease, so detection of the muscle invasion by
T2WI and contrast enhanced images was important to
differentiate between superﬁcial and invasive disease, also
detection of perivesical fat inﬁltration by T1WI and DWI
was very helpful in differentiation between organ-conﬁned
versus non-organ-conﬁned disease.
This study revealed that 20/30 patients (67%) were in stage
2 and 6/30 patients (20%) were in stage 3 while stage I included
4/30 patients (13%). There were no cases with stage 4, also
there were no patients with stage TX, To, Ta and Tis. These
results were in harmony with those reported by Tekes et al.
(12) and Dighe et al. (6) who reported that 64% of their cases
were in stage 2 while 19% of patients were in stage 3.
Regarding pathological comparison, we found that 26/30
patients were correctly staged, 4/30 patients were overstaged
due to peritumoral inﬂammatory changes which mimic tumors
on T2 W.I., while no cases were understaged. Watanabe et al.
(18) were in agreement with our study as they concluded that
overstaging is the most frequent error in MRI staging of blad-
der cancer.
With respect to results of histological examination of the
transurethral endoscopic biopsy taken in our study from 30
patients, about 93% had TCC and 7% had SCC. These results
were in agreement with Gandrup et al. (19) who reported that
more than 90% of bladder cancers are transitional cell
carcinomas.
This study revealed that all urinary bladder carcinomas
were restricted in DWI and the ADC values of the carcinomas
were signiﬁcantly lower compared with those of urine, normal
bladder wall, prostate, and seminal vesicle. There was no over-
lap between the ADC values of the tumors and the urine.
These results are in harmony with those reported by Matsuki
et al. (20).
Also these results were in agreement with El-Assmy et al.
(3) who did their study on 43 patients and revealed that all car-
cinomas in the 43 patients were clearly shown as high signal
intensity (SI) relative to the surrounding structures so, proper
staging was obtained. There were no false-positive cases and
results were quite similar to those of our study.
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were quite similar as they revealed close ranges of ADC values.
These results agreed with El-Assmy et al. (3) who revealed that
ADC values for different histological subtypes have no clear
cut off point or statistical signiﬁcant difference.
Matsuki et al. (20) also reported that ADCs of urinary
bladder cancers were lower than those of the surrounding
structures. The results of Matsuki et al. (20) are in harmony
with results of our study which revealed statistically signiﬁcant
differences between ADCs of urinary bladder and surrounding
structures.
In our study, the mean ADC of G3 tumors was signiﬁcantly
lower than that of G1 and G2 tumors, and all G3 tumors had
an ADC less than 1.0 · 103 mm2/s. These results were in
agreement with Wang et al. (21) who reported that ADC of
low-grade tumors were signiﬁcantly (p< 0.001) higher than
those of high-grade tumors (0.772 ± 0.091 · 103 mm2/s,
0.276 ± 0.033 · 103 mm2/s).
Takeuchi et al. (22) also reported that an inﬂammatory
change or ﬁbrosis surrounding the tumor mimics the invasion
of bladder cancer on T2-weighted imaging or enhanced MRI
and could lead to overstaging, but DWI could differentiate
between them clearly because these benign changes do not
show high SI on DWI.
5. Conclusion
Accurate prediction for T staging of urinary bladder carci-
noma can be made by means of DWI and ADC quantiﬁcation.
ADC value is a beneﬁcial method for providing information
about grade of bladder carcinomas.
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